ProQR Therapeutics N.V. PRQR
1.31 USD -0.01 (-0.38%)
Nov 11, 2026, 2:24 PM EST
1.30 Day range 1.35
1.20 52-week range 2.49
- YTD
- -35.40%
- 1 year
- -39.58%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 16.35M | 19.55M | 9.53M | 4.36M | 2.38M | |
| 16.35M | 19.55M | 9.53M | 4.36M | 2.38M | |
| -43.45M | -30.47M | -31.86M | -65.16M | -57.21M | |
| -42.18M | -27.76M | -28.12M | -64.42M | -60.74M | |
| -0.40 | -0.32 | -0.35 | -0.90 | -0.95 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 92.41M | 149.41M | 118.92M | 94.78M | 187.52M | |
| 112.76M | 167.96M | 137.88M | 171.32M | 209.58M | |
| 63.38M | 79.40M | 96.49M | 104.64M | 96.35M | |
| 15.96M | 17.22M | 19.73M | 21.97M | 60.37M | |
| 49.37M | 88.56M | 41.39M | 67.06M | 113.83M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -54.59M | -39.07M | 19.67M | -64.76M | -26.01M | |
| -1.02M | -4.07M | 4.28M | -702.00K | -425.00K | |
| -1.84M | 70.28M | -2.27M | -30.89M | 136.83M | |
| -1.02M | -1.42M | 6.63M | -702.00K | -425.00K | |
| -55.65M | 29.81M | 23.55M | -100.10M | 110.39M |